Startups

Head of Business Development

Ataraxis AI · New York (Remote Possible) · Remote

← All jobs
About Ataraxis AI

Transforming Cancer Care with AI Precision Medicine. Backed by AIX Ventures.

About the role

You will build Ataraxis's pharma partnership business from the ground up. Ataraxis has developed prognostic and predictive AI models validated in breast cancer, with potential applications across drug development, such as companion diagnostics, biomarker discovery, patient stratification, and trial rescue. This role owns pharma as a revenue stream alongside our diagnostics business. In that process, you will: Found on 1752vc Careers, the job board for startup and VC roles.

What they're looking for

  • 8+ years in pharma and/or diagnostics business development, from inside pharma or from a diagnostics or technology company selling into pharma
  • Preferred: MD, PhD, PharmD, NP, or a Master’s degree in cancer biology, molecular biology, cell biology, biomedical sciences, pharmacology, pharmaceutical sciences, or a related life sciences field
  • Documented track record of leading or co-leading pharma deals in companion diagnostics, biomarkers, patient stratification, or similar. If you did not formally lead one, we want evidence you were pivotal in getting it done
  • Built a pharma partnership pipeline from scratch, or decided from the pharma side which partnerships got funded
  • Fluency in how pharma makes partnership decisions: who decides, where the budget sits within a business unit, and how deals actually get pushed through
  • Relationships across large and mid-cap oncology pharma that you can activate now
More about this role

Ataraxis is a clinical AI research lab working at the intersection of multi-modal AI and precision medicine. Our goal is to make disease predictable. To accomplish this, we develop new AI methods that predict patient outcomes and treatment response, and build clinical tools to assist physicians in selecting the most optimal treatments for their patients.

Our AI research lab discovers and develops methods to recognize patterns and predict outcomes across complex, multi-modal clinical data. This spans our causality (Ataraxis™ Tau), foundation model (Falcon and Kestrel for digital pathology), and survival analysis research.

Our first clinical products, such as Ataraxis™ Breast for breast cancer, already help patients get the most appropriate treatment across the best academic institutions and community clinics worldwide.

At Ataraxis, you will have a unique opportunity to shape not only the future of our company, but also the future of healthcare. You will join an exceptional team at the forefront of clinical AI research and deployment. Our advisors include AI pioneers such as our founding advisor, Yann LeCun, and distinguished oncologists from top cancer research institutions, all...

Read the full posting on Ataraxis AI's site ↗

Commercial

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.